Prothena Corp PLC (PRTA)

58.73
NASDAQ : Health Care
Prev Close 56.99
Day Low/High 55.63 / 59.00
52 Wk Low/High 33.53 / 68.18
Avg Volume 259.20K
Exchange NASDAQ
Shares Outstanding 38.02M
Market Cap 2.17B
EPS -4.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

Prothena Raises $155.3M to Bring Anti-Organ Failure Drug to Market

The biotech company plans to commercialize its treatment for AL amyloidosis, a disease that causes protein to build up in the blood.

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Biotech Premarket Movers: Karyopharm, Lexicon, Prothena

Karyopharm Therapeutics falls 18%; Lexicon rises on drug approval.

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

First-In-Human Assessment Of PRX002, Prothena's Anti-Alpha Synuclein Antibody For Parkinson's Disease, Published In Movement Disorders Journal

Data Previously Presented in 2015 at 19th International Congress of Parkinson's Disease and Movement Disorders